In Silico

AI-enabled bioinformatics platform for drug discovery and biomarker development

placeCambridge, Massachusetts, United States calendar_todayFounded 2014 groups300 employees language insilico.com

Registered entities

Reputation

Customer rating 3.2 / 5 across 1 reviews.

Social engagement

Social engagement: 87.8K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

38 investors on record; lead investors include Prosperity7 Ventures, Qiming Venture Partners, Warburg Pincus, Deep Knowledge Ventures; 1 has since exited.

Investor typeCountShare
Venture capital2361%
Private equity513%
Accelerator & incubator13%
Bank & private debt13%
Other / undisclosed821%
Coming soon